NDC 72275-708

Lidovix Delayed Release

Lidocaine, Diclofenac Sodium

Lidovix Delayed Release is a Oral; Topical Kit in the Human Prescription Drug category. It is labeled and distributed by Primary Pharmaceuticals, Inc.. The primary component is .

Product ID72275-708_8f896469-4df2-599c-e053-2a95a90ac924
NDC72275-708
Product TypeHuman Prescription Drug
Proprietary NameLidovix Delayed Release
Generic NameLidocaine, Diclofenac Sodium
Dosage FormKit
Route of AdministrationORAL; TOPICAL
Marketing Start Date2019-08-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NamePrimary Pharmaceuticals, Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72275-708-77

1 BOX in 1 CARTON (72275-708-77) > 1 BOTTLE in 1 BOX > 1 KIT in 1 BOTTLE * 60 TABLET, DELAYED RELEASE in 1 BOTTLE * 30 POUCH in 1 CARTON (0591-3525-30) > 1 g in 1 POUCH
Marketing Start Date2019-08-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72275-708-77 [72275070877]

Lidovix Delayed Release KIT
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-08-01

Drug Details

OpenFDA Data

SPL SET ID:8f880f4b-07b1-3650-e053-2995a90a5549
Manufacturer
RxNorm Concept Unique ID - RxCUI
  • 1745091
  • 855926

  • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.